U.S. Markets close in 2 hrs 14 mins

See what the IHS Markit Score report has to say about Acorda Therapeutics Inc.

IHS Markit

Acorda Therapeutics Inc

NASDAQ/NGS:ACOR

Score: Negative (30)

19 days at current score.

Downgraded from Neutral on August 31st 2017

View full report here!

Summary


  • This company ranked negatively compared to the Healthcare sector despite 1 positive IHS Markit Category
  • Bearish sentiment is moderate and declining
  • Economic output in this company's sector is expanding


Bearish sentiment

Short interest | Neutral

Short interest is moderately high for ACOR with between 10 and 15% of shares outstanding currently on loan. However, this was an improvement in sentiment as investors who seek to profit from falling equity prices reduced their short positions on September 14.

Money flow

ETF/Index ownership | Neutral

ETF activity is neutral. ETFs that hold ACOR had net inflows of $3.32 billion over the last one-month. While these are not among the highest inflows of the last year, the rate of inflow is increasing.

Economic sentiment

PMI by IHS Markit | Positive

According to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year.

Credit worthiness

Credit default swap

CDS data is not available for this security.

Please send all inquiries related to the report to score@ihsmarkit.com.

Charts and report PDFs will only be available for 30 days after publishing.

This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.